Hematology/Oncology

Top Story

‘Smarter and stronger’ T cells offer hope for more effective, less toxic cancer therapy

‘Smarter and stronger’ T cells offer hope for more effective, less toxic cancer therapy
August 18, 2019
Commentary

New targets, treatment strategies create ‘exciting time’ in triple-negative breast cancer

August 17, 2019
Although breast cancer mortality has declined by 40% over the past several decades, more than 40,000 women will die of the disease this year, according to SEER data. …
In the Journals

Teratoma linked to higher cumulative incidence of germ cell tumor-related death

August 16, 2019
Teratoma appeared associated with a higher cumulative incidence of disease-related death among men with nonseminomatous germ cell primary tumors, according to results of…
FDA News

FDA approves Inrebic for myelofibrosis

August 16, 2019
The FDA today approved fedratinib for the treatment of adults with intermediate-2 or high-risk primary or secondary myelofibrosis. “Myelofibrosis can cause…
In the Journals

Avoid skin markings in dermoscopic images for analysis, training by convolutional neural networks

August 16, 2019
Melanoma probability scores increased due to standard skin markings from surgical ink and were associated with a significant reduction in the specificity of a…
More Headlines »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Bristol-Myers Squibb.

For patients diagnosed with metastatic melanoma, the lifetime incidence of brain metastasis is more than 50% and is…
More »
Video
Meeting News

VIDEO: Intensity Therapeutics’ intratumoral formulation active in highly refractory cancers

June 26, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer

CME ABIM MOC

Ace the Case: A 54-year-old Man With 2 Weeks of Progressive Shortness of Breath

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 54-year-old man with 2 weeks of…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next